Clinical Trials
2 trialsNCT05030675 2025-02-13
Fostamatinib for the Treatment of Lower-risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Who Have Failed Therapy With Hypomethylating Agents
M.D. Anderson Cancer Center
Phase 1 Completed
NCT02611063 2023-03-17
Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant
Duke University
Phase 1 Completed